References
[1]. Siegel, R. L., Kratzer, T. B., Giaquinto, A. N., Sung, H., & Jemal, A. (2025). Cancer statistics, 2025. CA: A Cancer Journal for Clinicians, 75(1), 10–45.
[2]. Bangham, A. D., Hill, M. W., & Miller, N. G. A. (n.d.). Preparation and use of liposomes as models of biological membranes.
[3]. Large, D. E., Abdelmessih, R. G., Fink, E. A., & Auguste, D. T. (2021). Liposome composition in drug delivery design, synthesis, characterization, and clinical application. Advanced Drug Delivery Reviews, 176, 113851.
[4]. Akbarzadeh, A., Rezaei-Sadabady, R., Davaran, S., Joo, S. W., Zarghami, N., Hanifehpour, Y., Samiei, M., Kouhi, M., & Nejati-Koshki, K. (2013). Liposome: Classification, preparation, and applications. Nanoscale Research Letters, 8(1), 102.
[5]. Ibrahim, M. (2022). Polyethylene glycol (PEG): The nature, immunogenicity, and role in the hypersensitivity of PEGylated products. Journal of Controlled Release.
[6]. Mufamadi, M. S., Pillay, V., Choonara, Y. E., Du Toit, L. C., Modi, G., Naidoo, D., & Ndesendo, V. M. K. (2011). A review on composite liposomal technologies for specialized drug delivery. Journal of Drug Delivery, 2011, 1–19.
[7]. Sang, R., Stratton, B., Engel, A., & Deng, W. (2021). Liposome technologies towards colorectal cancer therapeutics. Acta Biomaterialia, 127, 24–40.
[8]. Jesorka, A., & Orwar, O. (2008). Liposomes: Technologies and analytical applications. Annual Review of Analytical Chemistry, 1(1), 801–832.
[9]. Gulati, M., Grover, M., Singh, S., & Singh, M. (1998). Lipophilic drug derivatives in liposomes. International Journal of Pharmaceutics, 165(2), 129–168.
[10]. Rideau, E., Dimova, R., Schwille, P., Wurm, F. R., & Landfester, K. (2018). Liposomes and polymersomes: A comparative review towards cell mimicking. Chemical Society Reviews, 47(23), 8572–8610.
[11]. Nogueira, E., Gomes, A. C., Preto, A., & Cavaco-Paulo, A. (2015). Design of liposomal formulations for cell targeting. Colloids and Surfaces, B: Biointerfaces, 136, 514–526.
[12]. D’Souza, G. G. M., & Zhang, H. (Eds.). (2023). Liposomes: Methods and protocols (Vol. 2622). Springer US.
[13]. Ajeeshkumar, K. K., Aneesh, P. A., Raju, N., Suseela, M., Ravishankar, C. N., & Benjakul, S. (2021). Advancements in liposome technology: Preparation techniques and applications in food, functional foods, and bioactive delivery: A review. Comprehensive Reviews in Food Science and Food Safety, 20(2), 1280–1306.
[14]. Yun, J.-S., Hwangbo, S.-A., & Jeong, Y.-G. (2023). Preparation of Uniform Nano Liposomes Using Focused Ultrasonic Technology. Nanomaterials, 13(19), 2618.
[15]. Kim, E., Graceffa, O., Broweleit, R., Ladha, A., Boies, A., & Rawle, R. J. (2024). Lipid loss and compositional change during preparation of liposomes by common biophysical methods. Biophysics.
[16]. Vitali, A., Paolicelli, P., Bigi, B., Trilli, J., Di Muzio, L., Carriero, V. C., Casadei, M. A., & Petralito, S. (2024). Liposome encapsulation of the palmitoyl–KTTKS peptide: Structural and functional characterization. Pharmaceutics, 16(2), 219.
[17]. Abedi Cham Heidari, Z., Ghanbarikondori, P., Mortazavi Mamaghani, E., Hheidari, A., Saberian, E., Mozaffari, E., Alizadeh, M., & Allahyartorkaman, M. (2023). Characteristics and cytotoxic effects of nano-liposomal paclitaxel on gastric cancer cells. Asian Pacific Journal of Cancer Prevention, 24(9), 3291–3296.
[18]. Wang, B., Xu, Q., Zhou, C., & Lin, Y. (2021). Liposomes co-loaded with ursolic acid and ginsenoside Rg3 in the treatment of hepatocellular carcinoma. Acta Biochimica Polonica.
[19]. Ashrafzadeh, M. S., Akbarzadeh, A., Heydarinasab, A., & Ardjmand, M. (2020). In vivo glioblastoma therapy using targeted liposomal cisplatin. International Journal of Nanomedicine, Volume 15, 7035–7049.
[20]. Wehrle, N., Tran, L. M., Zheng, A., Pissay, R., & Park, Y. C. (2024). Effect of solvent and cholesterol on liposome production by the reverse-phase evaporation (RPE) method. Langmuir, 40(44), 23521–23528.
[21]. López, R. R., G. Font De Rubinat, P., Sánchez, L.-M., Tsering, T., Alazzam, A., Bergeron, K.-F., Mounier, C., Burnier, J. V., Stiharu, I., & Nerguizian, V. (2021). The effect of different organic solvents in liposome properties produced in a periodic disturbance mixer: Transcutol®, a potential organic solvent replacement. Colloids and Surfaces, B: Biointerfaces, 198, 111447.
[22]. Karim, A. S., & Jewett, M. C. (Eds.). (2022). Cell-free gene expression: Methods and protocols (Vol. 2433). Springer US.
[23]. Zhou, L., Xie, H., Chen, X., Wan, J., Xu, S., Han, Y., Chen, D., Qiao, Y., Zhou, L., Zheng, S., & Wang, H. (2020). Dimerization-induced self-assembly of a redox-responsive prodrug into nanoparticles for improved therapeutic index. Acta Biomaterialia, 113, 464–477.
[24]. Alavi, S. E., Raza, A., Koohi Moftakhari Esfahani, M., Akbarzadeh, A., Abdollahi, S. H., & Ebrahimi Shahmabadi, H. (2022). Carboplatin niosomal nanoplatform for potentiated chemotherapy. Journal of Pharmaceutical Sciences, 111(11), 3029–3037.
[25]. Tang, H., Xie, Y., Zhu, M., Jia, J., Liu, R., Shen, Y., Zheng, Y., Guo, X., Miao, D., & Pei, J. (2022). Estrone-conjugated PEGylated liposome Co-loaded paclitaxel and carboplatin improve anti-tumor efficacy in ovarian cancer and reduce acute toxicity of chemo-drugs. International Journal of Nanomedicine, Volume 17, 3013–3041.
[26]. Zhang, Z.-A., Xin, X., Liu, C., Liu, Y., Duan, H.-X., Qi, L., Zhang, Y.-Y., Zhao, H., Chen, L.-Q., Jin, M.-J., Gao, Z.-G., & Huang, W. (2021). Novel brain-targeted nanomicelles for anti-glioma therapy mediated by the ApoE-enriched protein corona in vivo. Journal of Nanobiotechnology, 19(1), 453.
[27]. Yang, Y., Chu, Y., Li, C., Fan, L., Lu, H., Zhan, C., & Zhang, Z. (2024). Brain-targeted drug delivery by in vivo functionalized liposome with stable D-peptide ligand. Journal of Controlled Release, 373, 240–251.
[28]. Li, P., Li, J., Cheng, J., Huang, J., Li, J., Xiao, J., & Duan, X. (2025). Hypoxia-responsive liposome enhances intracellular delivery of photosensitizer for effective photodynamic therapy. Journal of Controlled Release, 377, 277–287.
[29]. Turánek, J., Kosztyu, P., Turánek Knötigová, P., Bartheldyová, E., Hubatka, F., Odehnalová, N., Mikulík, R., Vaškovicová, N., Čelechovská, H., Kratochvílová, I., Fekete, L., Tavares, M. R., Chytil, P., Raška, M., & Etrych, T. (2024). Long circulating liposomal platform utilizing hydrophilic polymer-based surface modification: Preparation, characterisation, and biological evaluation. International Journal of Pharmaceutics, 661, 124465.
[30]. Aghdam, M. A., Bagheri, R., Mosafer, J., Baradaran, B., Hashemzaei, M., Baghbanzadeh, A., Guardia, M. de la, & Mokhtarzadeh, A. (2019). Recent advances on thermosensitive and pH-sensitive liposomes employed in controlled release. Journal of Controlled Release, 315, 1–22.
[31]. Needham, D., Anyarambhatla, G., Kong, G., & Dewhirst, M. W. (2000). A new temperature-sensitive liposome for use with mild hyperthermia: Characterization and testing in a human tumor xenograft model. Cancer Research, 60(5), 1197–1201.
[32]. Wang, X., & Allen, C. (2025). Synergistic effects of thermosensitive liposomal doxorubicin, mild hyperthermia, and radiotherapy in breast cancer management: An orthotopic mouse model study. Drug Delivery and Translational Research, 15(3), 1011–1022.
[33]. Amin, M., Lammers, T., & Ten Hagen, T. L. M. (2022). Temperature-sensitive polymers to promote heat-triggered drug release from liposomes: Towards bypassing EPR. Advanced Drug Delivery Reviews, 189, 114503.
[34]. Paredes, F., Williams, H. C., & San Martin, A. (2021). Metabolic adaptation in hypoxia and cancer. Cancer Letters, 502, 133–142.
[35]. Hu, F., Yue, H., Lu, T., & Ma, G. (2020). Cytosolic delivery of HBsAg and enhanced cellular immunity by pH-responsive liposome. Journal of Controlled Release, 324, 460–470.
[36]. De Oliveira Silva, J., Fernandes, R. S., De Alcântara Lemos, J., Cassali, G. D., De Paula Sabino, A., Townsend, D. M., Oliveira, M. C., & De Barros, A. L. B. (2023). Evaluation of acute toxicity and in vitro antitumor activity of a novel doxorubicin-loaded folate-coated pH-sensitive liposome. Biomedicine & Pharmacotherapy, 165, 115280.
[37]. Zhao, Y., Le, T. M. D., Hong, J., Jiao, A., Yoon, A.-R., & Yun, C.-O. (2024). Smart accumulating dual-targeting lipid envelopes equipping oncolytic adenovirus for enhancing cancer gene therapeutic efficacy. ACS Nano, 18(41), 27869–27890.
[38]. Zhao, T., Liang, C., Zhao, Y., Xue, X., Ma, Z., Qi, J., Shen, H., Yang, S., Zhang, J., Jia, Q., Du, Q., Cao, D., Xiang, B., Zhang, H., & Qi, X. (2022). Multistage pH-responsive codelivery liposomal platform for synergistic cancer therapy. Journal of Nanobiotechnology, 20(1), 177.
[39]. Shen, Y., Zhong, B., Zheng, W., Wang, D., Chen, L., Song, H., Pan, X., Mo, S., Jin, B., Cui, H., Zhan, H., Luo, F., & Liu, J. (2024). Rg3-lipo biomimetic delivery of paclitaxel enhances targeting of tumors and myeloid-derived suppressor cells. Journal of Clinical Investigation, 134(22), e178617.
[40]. Wu, M., Wang, Q., Chen, S., Zhou, Z., Li, J., Sun, H., Liu, J., Wang, G., Zhou, F., & Sun, M. (2022). Metabolic intervention liposome for targeting glutamine-addiction of breast cancer. Journal of Controlled Release, 350, 1–10.
[41]. George, T. A., Chen, M. M., Czosseck, A., Chen, H.-P., Huang, H.-S., & Lundy, D. J. (2022). Liposome-encapsulated anthraquinone improves efficacy and safety in triple negative breast cancer. Journal of Controlled Release, 342, 31–43.
[42]. Luo, K., Yang, L., Yan, C., Zhao, Y., Li, Q., Liu, X., Xie, L., Sun, Q., & Li, X. (2023). A dual‐targeting liposome enhances triple‐negative breast cancer chemoimmunotherapy through inducing immunogenic cell death and inhibiting STAT3 activation. Small, 19(40), 2302834.
[43]. Miao, Y., Chen, M., Zhou, X., Guo, L., Zhu, J., Wang, R., Zhang, X., & Gan, Y. (2021). Chitosan oligosaccharide modified liposomes enhance lung cancer delivery of paclitaxel. Acta Pharmacologica Sinica, 42(10), 1714–1722.
[44]. Xie, S., Zhu, J., Peng, Y., Zhan, F., Zhan, F., He, C., Feng, D., Xie, J., Liu, J., Zhu, H., Yao, H., Xu, J., Su, Z., & Xu, S. (2025). In vivo self‐assembly of PROTACs by bioorthogonal chemistry for precision cancer therapy. Angewandte Chemie International Edition, 64(11), e202421713.
[45]. Zhou, F., Li, X., Xue, X., Li, S., Fan, G., Cai, Y., Chang, Z., Qu, J., & Liu, R. (2023). A novel tri‐functional liposome Re‐educates “cold tumor” and abrogates tumor growth by synergizing autophagy inhibition and PD‐L1 blockade. Advanced Healthcare Materials, 12(11), 2202757.
[46]. Zhu, T., Chen, Z., Jiang, G., & Huang, X. (2023). Sequential targeting hybrid nanovesicles composed of chimeric antigen receptor T-cell-derived exosomes and liposomes for enhanced cancer immunochemotherapy. ACS Nano, 17(17), 16770–16786.
[47]. Liu, Y., Crowe, W. N., Wang, L., Petty, W. J., Habib, A. A., & Zhao, D. (2023). Aerosolized immunotherapeutic nanoparticle inhalation potentiates PD-L1 blockade for locally advanced lung cancer. Nano Research, 16(4), 5300–5310.
[48]. Sun, B., Li, R., Ji, N., Liu, H., Wang, H., Chen, C., Bai, L., Su, J., & Chen, J. (2025). Brain-targeting drug delivery systems: The state of the art in treatment of glioblastoma. Materials Today Bio, 30, 101443.
[49]. Liu, P., Lan, S., Gao, D., Hu, D., Chen, Z., Li, Z., Jiang, G., & Sheng, Z. (2024). Targeted blood-brain barrier penetration and precise imaging of infiltrative glioblastoma margins using hybrid cell membrane-coated ICG liposomes. Journal of Nanobiotechnology, 22(1), 603.
[50]. Chen, P., Liu, Y., Huang, H., Li, M., Xie, H., Roy, S., Gu, J., Jin, J., Deng, K., Du, L., & Guo, B. (2025). Genetically engineered IL12/CSF1R‐macrophage membrane‐liposome hybrid nanovesicles for NIR‐II fluorescence imaging‐guided and membrane‐targeted mild photothermal‐immunotherapy of glioblastoma. Advanced Science, 12(23), 2500131.
[51]. Meng, J.-L., Dong, Z.-X., Chen, Y.-R., Lin, M.-H., Liu, Y.-C., Roffler, S. R., Lin, W.-W., Chang, C.-Y., Tzou, S.-C., Cheng, T.-L., Huang, H.-C., Li, Z.-Q., Lin, Y.-C., & Su, Y.-C. (2025). pH-responsive polyethylene glycol engagers for enhanced brain delivery of PEGylated nanomedicine to treat glioblastoma. ACS Nano, 19(1), 307–321.
[52]. Sharifi, M., Cho, W. C., Ansariesfahani, A., Tarharoudi, R., Malekisarvar, H., Sari, S., Bloukh, S. H., Edis, Z., Amin, M., Gleghorn, J. P., Hagen, T. L. M. T., & Falahati, M. (2022). An updated review on EPR-based solid tumor targeting nanocarriers for cancer treatment. Cancers, 14(12), 2868.